nodes	percent_of_prediction	percent_of_DWPC	metapath
Lamotrigine—Pyrimethamine—DHFR—bone cancer	0.0568	1	CrCbGaD
Lamotrigine—SCN5A—Cardiac Progenitor Differentiation—T—bone cancer	0.00311	0.0836	CbGpPWpGaD
Lamotrigine—UGT1A4—Tamoxifen metabolism—CYP3A4—bone cancer	0.0019	0.0512	CbGpPWpGaD
Lamotrigine—UGT1A3—Estrogen metabolism—CYP3A4—bone cancer	0.00179	0.0481	CbGpPWpGaD
Lamotrigine—UGT1A4—Metapathway biotransformation—CYP4V2—bone cancer	0.00177	0.0475	CbGpPWpGaD
Lamotrigine—SCN5A—SIDS Susceptibility Pathways—FEV—bone cancer	0.00154	0.0415	CbGpPWpGaD
Lamotrigine—UGT1A3—Metapathway biotransformation—CYP4V2—bone cancer	0.00147	0.0394	CbGpPWpGaD
Lamotrigine—UGT1A4—Constitutive Androstane Receptor Pathway—CYP3A4—bone cancer	0.00136	0.0365	CbGpPWpGaD
Lamotrigine—UGT1A3—Constitutive Androstane Receptor Pathway—CYP3A4—bone cancer	0.00113	0.0304	CbGpPWpGaD
Lamotrigine—ABCB1—Codeine and Morphine Metabolism—CYP3A4—bone cancer	0.00109	0.0292	CbGpPWpGaD
Lamotrigine—ABCB1—Drug Induction of Bile Acid Pathway—NR1I2—bone cancer	0.00102	0.0273	CbGpPWpGaD
Lamotrigine—ABCB1—HIF-1-alpha transcription factor network—CITED2—bone cancer	0.00102	0.0273	CbGpPWpGaD
Lamotrigine—Neutropenia—Doxorubicin—bone cancer	0.000942	0.00104	CcSEcCtD
Lamotrigine—Haemoglobin—Methotrexate—bone cancer	0.000936	0.00103	CcSEcCtD
Lamotrigine—Haemorrhage—Methotrexate—bone cancer	0.000931	0.00103	CcSEcCtD
Lamotrigine—Hepatitis—Methotrexate—bone cancer	0.000931	0.00103	CcSEcCtD
Lamotrigine—Sweating—Epirubicin—bone cancer	0.000931	0.00103	CcSEcCtD
Lamotrigine—Pollakiuria—Doxorubicin—bone cancer	0.000931	0.00103	CcSEcCtD
Lamotrigine—Haematuria—Epirubicin—bone cancer	0.000926	0.00102	CcSEcCtD
Lamotrigine—Pharyngitis—Methotrexate—bone cancer	0.000924	0.00102	CcSEcCtD
Lamotrigine—Photosensitivity reaction—Doxorubicin—bone cancer	0.000919	0.00101	CcSEcCtD
Lamotrigine—Weight increased—Doxorubicin—bone cancer	0.000917	0.00101	CcSEcCtD
Lamotrigine—Epistaxis—Epirubicin—bone cancer	0.000916	0.00101	CcSEcCtD
Lamotrigine—Weight decreased—Doxorubicin—bone cancer	0.000911	0.00101	CcSEcCtD
Lamotrigine—Sinusitis—Epirubicin—bone cancer	0.000911	0.00101	CcSEcCtD
Lamotrigine—Hyperglycaemia—Doxorubicin—bone cancer	0.000909	0.001	CcSEcCtD
Lamotrigine—Agranulocytosis—Epirubicin—bone cancer	0.000906	0.001	CcSEcCtD
Lamotrigine—Pneumonia—Doxorubicin—bone cancer	0.000903	0.000997	CcSEcCtD
Lamotrigine—Drowsiness—Doxorubicin—bone cancer	0.000898	0.000991	CcSEcCtD
Lamotrigine—Infestation NOS—Doxorubicin—bone cancer	0.000898	0.000991	CcSEcCtD
Lamotrigine—Infestation—Doxorubicin—bone cancer	0.000898	0.000991	CcSEcCtD
Lamotrigine—Stevens-Johnson syndrome—Doxorubicin—bone cancer	0.00089	0.000983	CcSEcCtD
Lamotrigine—Hypersensitivity—Cisplatin—bone cancer	0.000888	0.00098	CcSEcCtD
Lamotrigine—Renal failure—Doxorubicin—bone cancer	0.000883	0.000974	CcSEcCtD
Lamotrigine—Erythema multiforme—Methotrexate—bone cancer	0.00088	0.000972	CcSEcCtD
Lamotrigine—Neuropathy peripheral—Doxorubicin—bone cancer	0.00088	0.000972	CcSEcCtD
Lamotrigine—Haemoglobin—Epirubicin—bone cancer	0.000876	0.000967	CcSEcCtD
Lamotrigine—Stomatitis—Doxorubicin—bone cancer	0.000875	0.000966	CcSEcCtD
Lamotrigine—Rhinitis—Epirubicin—bone cancer	0.000874	0.000964	CcSEcCtD
Lamotrigine—Urinary tract infection—Doxorubicin—bone cancer	0.000873	0.000964	CcSEcCtD
Lamotrigine—Conjunctivitis—Doxorubicin—bone cancer	0.000873	0.000964	CcSEcCtD
Lamotrigine—Hepatitis—Epirubicin—bone cancer	0.000871	0.000962	CcSEcCtD
Lamotrigine—Haemorrhage—Epirubicin—bone cancer	0.000871	0.000962	CcSEcCtD
Lamotrigine—Eye disorder—Methotrexate—bone cancer	0.00087	0.00096	CcSEcCtD
Lamotrigine—Tinnitus—Methotrexate—bone cancer	0.000868	0.000958	CcSEcCtD
Lamotrigine—Hypoaesthesia—Epirubicin—bone cancer	0.000867	0.000957	CcSEcCtD
Lamotrigine—Asthenia—Cisplatin—bone cancer	0.000865	0.000955	CcSEcCtD
Lamotrigine—Pharyngitis—Epirubicin—bone cancer	0.000865	0.000955	CcSEcCtD
Lamotrigine—Sweating—Doxorubicin—bone cancer	0.000861	0.00095	CcSEcCtD
Lamotrigine—Oedema peripheral—Epirubicin—bone cancer	0.000858	0.000947	CcSEcCtD
Lamotrigine—Haematuria—Doxorubicin—bone cancer	0.000856	0.000945	CcSEcCtD
Lamotrigine—Connective tissue disorder—Epirubicin—bone cancer	0.000856	0.000945	CcSEcCtD
Lamotrigine—Epistaxis—Doxorubicin—bone cancer	0.000847	0.000935	CcSEcCtD
Lamotrigine—Angiopathy—Methotrexate—bone cancer	0.000845	0.000932	CcSEcCtD
Lamotrigine—Sinusitis—Doxorubicin—bone cancer	0.000843	0.00093	CcSEcCtD
Lamotrigine—Mediastinal disorder—Methotrexate—bone cancer	0.000839	0.000926	CcSEcCtD
Lamotrigine—Agranulocytosis—Doxorubicin—bone cancer	0.000838	0.000925	CcSEcCtD
Lamotrigine—Chills—Methotrexate—bone cancer	0.000835	0.000922	CcSEcCtD
Lamotrigine—Diarrhoea—Cisplatin—bone cancer	0.000825	0.00091	CcSEcCtD
Lamotrigine—Erythema multiforme—Epirubicin—bone cancer	0.000824	0.000909	CcSEcCtD
Lamotrigine—Alopecia—Methotrexate—bone cancer	0.000823	0.000908	CcSEcCtD
Lamotrigine—Mental disorder—Methotrexate—bone cancer	0.000816	0.0009	CcSEcCtD
Lamotrigine—Eye disorder—Epirubicin—bone cancer	0.000814	0.000899	CcSEcCtD
Lamotrigine—Tinnitus—Epirubicin—bone cancer	0.000812	0.000897	CcSEcCtD
Lamotrigine—Malnutrition—Methotrexate—bone cancer	0.000811	0.000895	CcSEcCtD
Lamotrigine—Erythema—Methotrexate—bone cancer	0.000811	0.000895	CcSEcCtD
Lamotrigine—Haemoglobin—Doxorubicin—bone cancer	0.00081	0.000894	CcSEcCtD
Lamotrigine—Flushing—Epirubicin—bone cancer	0.000809	0.000893	CcSEcCtD
Lamotrigine—Rhinitis—Doxorubicin—bone cancer	0.000808	0.000892	CcSEcCtD
Lamotrigine—Haemorrhage—Doxorubicin—bone cancer	0.000806	0.00089	CcSEcCtD
Lamotrigine—Hepatitis—Doxorubicin—bone cancer	0.000806	0.00089	CcSEcCtD
Lamotrigine—Hypoaesthesia—Doxorubicin—bone cancer	0.000802	0.000885	CcSEcCtD
Lamotrigine—Pharyngitis—Doxorubicin—bone cancer	0.0008	0.000883	CcSEcCtD
Lamotrigine—Oedema peripheral—Doxorubicin—bone cancer	0.000794	0.000877	CcSEcCtD
Lamotrigine—Dysgeusia—Methotrexate—bone cancer	0.000794	0.000876	CcSEcCtD
Lamotrigine—Connective tissue disorder—Doxorubicin—bone cancer	0.000792	0.000875	CcSEcCtD
Lamotrigine—Angiopathy—Epirubicin—bone cancer	0.000791	0.000873	CcSEcCtD
Lamotrigine—Mediastinal disorder—Epirubicin—bone cancer	0.000785	0.000867	CcSEcCtD
Lamotrigine—Back pain—Methotrexate—bone cancer	0.000784	0.000865	CcSEcCtD
Lamotrigine—Chills—Epirubicin—bone cancer	0.000782	0.000863	CcSEcCtD
Lamotrigine—Alopecia—Epirubicin—bone cancer	0.00077	0.00085	CcSEcCtD
Lamotrigine—Vomiting—Cisplatin—bone cancer	0.000767	0.000846	CcSEcCtD
Lamotrigine—Vision blurred—Methotrexate—bone cancer	0.000764	0.000843	CcSEcCtD
Lamotrigine—Mental disorder—Epirubicin—bone cancer	0.000763	0.000843	CcSEcCtD
Lamotrigine—Erythema multiforme—Doxorubicin—bone cancer	0.000762	0.000841	CcSEcCtD
Lamotrigine—Rash—Cisplatin—bone cancer	0.00076	0.000839	CcSEcCtD
Lamotrigine—Dermatitis—Cisplatin—bone cancer	0.000759	0.000838	CcSEcCtD
Lamotrigine—Malnutrition—Epirubicin—bone cancer	0.000759	0.000837	CcSEcCtD
Lamotrigine—Erythema—Epirubicin—bone cancer	0.000759	0.000837	CcSEcCtD
Lamotrigine—Eye disorder—Doxorubicin—bone cancer	0.000754	0.000832	CcSEcCtD
Lamotrigine—Ill-defined disorder—Methotrexate—bone cancer	0.000752	0.00083	CcSEcCtD
Lamotrigine—Tinnitus—Doxorubicin—bone cancer	0.000752	0.00083	CcSEcCtD
Lamotrigine—Anaemia—Methotrexate—bone cancer	0.000749	0.000827	CcSEcCtD
Lamotrigine—Flushing—Doxorubicin—bone cancer	0.000748	0.000826	CcSEcCtD
Lamotrigine—Flatulence—Epirubicin—bone cancer	0.000747	0.000825	CcSEcCtD
Lamotrigine—Tension—Epirubicin—bone cancer	0.000744	0.000822	CcSEcCtD
Lamotrigine—Dysgeusia—Epirubicin—bone cancer	0.000743	0.00082	CcSEcCtD
Lamotrigine—Nervousness—Epirubicin—bone cancer	0.000737	0.000813	CcSEcCtD
Lamotrigine—Back pain—Epirubicin—bone cancer	0.000734	0.00081	CcSEcCtD
Lamotrigine—Angiopathy—Doxorubicin—bone cancer	0.000732	0.000807	CcSEcCtD
Lamotrigine—Malaise—Methotrexate—bone cancer	0.000731	0.000807	CcSEcCtD
Lamotrigine—Muscle spasms—Epirubicin—bone cancer	0.000729	0.000805	CcSEcCtD
Lamotrigine—Vertigo—Methotrexate—bone cancer	0.000728	0.000804	CcSEcCtD
Lamotrigine—Mediastinal disorder—Doxorubicin—bone cancer	0.000727	0.000802	CcSEcCtD
Lamotrigine—Leukopenia—Methotrexate—bone cancer	0.000726	0.000801	CcSEcCtD
Lamotrigine—Chills—Doxorubicin—bone cancer	0.000723	0.000799	CcSEcCtD
Lamotrigine—Nausea—Cisplatin—bone cancer	0.000716	0.00079	CcSEcCtD
Lamotrigine—Vision blurred—Epirubicin—bone cancer	0.000715	0.000789	CcSEcCtD
Lamotrigine—Alopecia—Doxorubicin—bone cancer	0.000712	0.000786	CcSEcCtD
Lamotrigine—Cough—Methotrexate—bone cancer	0.000707	0.000781	CcSEcCtD
Lamotrigine—Mental disorder—Doxorubicin—bone cancer	0.000706	0.00078	CcSEcCtD
Lamotrigine—Ill-defined disorder—Epirubicin—bone cancer	0.000704	0.000777	CcSEcCtD
Lamotrigine—Convulsion—Methotrexate—bone cancer	0.000702	0.000775	CcSEcCtD
Lamotrigine—Erythema—Doxorubicin—bone cancer	0.000702	0.000775	CcSEcCtD
Lamotrigine—Malnutrition—Doxorubicin—bone cancer	0.000702	0.000775	CcSEcCtD
Lamotrigine—Anaemia—Epirubicin—bone cancer	0.000701	0.000774	CcSEcCtD
Lamotrigine—Agitation—Epirubicin—bone cancer	0.000697	0.000769	CcSEcCtD
Lamotrigine—Flatulence—Doxorubicin—bone cancer	0.000692	0.000763	CcSEcCtD
Lamotrigine—Arthralgia—Methotrexate—bone cancer	0.00069	0.000762	CcSEcCtD
Lamotrigine—Chest pain—Methotrexate—bone cancer	0.00069	0.000762	CcSEcCtD
Lamotrigine—Myalgia—Methotrexate—bone cancer	0.00069	0.000762	CcSEcCtD
Lamotrigine—Tension—Doxorubicin—bone cancer	0.000689	0.00076	CcSEcCtD
Lamotrigine—Dysgeusia—Doxorubicin—bone cancer	0.000687	0.000759	CcSEcCtD
Lamotrigine—Malaise—Epirubicin—bone cancer	0.000684	0.000755	CcSEcCtD
Lamotrigine—Discomfort—Methotrexate—bone cancer	0.000682	0.000753	CcSEcCtD
Lamotrigine—Nervousness—Doxorubicin—bone cancer	0.000682	0.000752	CcSEcCtD
Lamotrigine—Vertigo—Epirubicin—bone cancer	0.000682	0.000752	CcSEcCtD
Lamotrigine—Syncope—Epirubicin—bone cancer	0.00068	0.000751	CcSEcCtD
Lamotrigine—Leukopenia—Epirubicin—bone cancer	0.000679	0.000749	CcSEcCtD
Lamotrigine—Back pain—Doxorubicin—bone cancer	0.000679	0.000749	CcSEcCtD
Lamotrigine—Muscle spasms—Doxorubicin—bone cancer	0.000675	0.000745	CcSEcCtD
Lamotrigine—Palpitations—Epirubicin—bone cancer	0.00067	0.00074	CcSEcCtD
Lamotrigine—Confusional state—Methotrexate—bone cancer	0.000667	0.000736	CcSEcCtD
Lamotrigine—Loss of consciousness—Epirubicin—bone cancer	0.000667	0.000736	CcSEcCtD
Lamotrigine—Cough—Epirubicin—bone cancer	0.000662	0.000731	CcSEcCtD
Lamotrigine—Vision blurred—Doxorubicin—bone cancer	0.000661	0.00073	CcSEcCtD
Lamotrigine—Convulsion—Epirubicin—bone cancer	0.000657	0.000725	CcSEcCtD
Lamotrigine—Infection—Methotrexate—bone cancer	0.000657	0.000725	CcSEcCtD
Lamotrigine—Hypertension—Epirubicin—bone cancer	0.000655	0.000723	CcSEcCtD
Lamotrigine—Ill-defined disorder—Doxorubicin—bone cancer	0.000651	0.000719	CcSEcCtD
Lamotrigine—Nervous system disorder—Methotrexate—bone cancer	0.000649	0.000716	CcSEcCtD
Lamotrigine—Anaemia—Doxorubicin—bone cancer	0.000649	0.000716	CcSEcCtD
Lamotrigine—Thrombocytopenia—Methotrexate—bone cancer	0.000648	0.000715	CcSEcCtD
Lamotrigine—Arthralgia—Epirubicin—bone cancer	0.000646	0.000713	CcSEcCtD
Lamotrigine—Myalgia—Epirubicin—bone cancer	0.000646	0.000713	CcSEcCtD
Lamotrigine—Chest pain—Epirubicin—bone cancer	0.000646	0.000713	CcSEcCtD
Lamotrigine—Agitation—Doxorubicin—bone cancer	0.000645	0.000712	CcSEcCtD
Lamotrigine—Anxiety—Epirubicin—bone cancer	0.000644	0.00071	CcSEcCtD
Lamotrigine—Hyperhidrosis—Methotrexate—bone cancer	0.00064	0.000706	CcSEcCtD
Lamotrigine—Discomfort—Epirubicin—bone cancer	0.000638	0.000704	CcSEcCtD
Lamotrigine—Malaise—Doxorubicin—bone cancer	0.000633	0.000699	CcSEcCtD
Lamotrigine—Dry mouth—Epirubicin—bone cancer	0.000632	0.000697	CcSEcCtD
Lamotrigine—Vertigo—Doxorubicin—bone cancer	0.000631	0.000696	CcSEcCtD
Lamotrigine—Anorexia—Methotrexate—bone cancer	0.000631	0.000696	CcSEcCtD
Lamotrigine—Syncope—Doxorubicin—bone cancer	0.000629	0.000695	CcSEcCtD
Lamotrigine—Leukopenia—Doxorubicin—bone cancer	0.000628	0.000693	CcSEcCtD
Lamotrigine—Confusional state—Epirubicin—bone cancer	0.000624	0.000689	CcSEcCtD
Lamotrigine—Palpitations—Doxorubicin—bone cancer	0.00062	0.000685	CcSEcCtD
Lamotrigine—Oedema—Epirubicin—bone cancer	0.000619	0.000683	CcSEcCtD
Lamotrigine—Loss of consciousness—Doxorubicin—bone cancer	0.000617	0.000681	CcSEcCtD
Lamotrigine—Infection—Epirubicin—bone cancer	0.000615	0.000679	CcSEcCtD
Lamotrigine—Cough—Doxorubicin—bone cancer	0.000612	0.000676	CcSEcCtD
Lamotrigine—Shock—Epirubicin—bone cancer	0.000609	0.000672	CcSEcCtD
Lamotrigine—Convulsion—Doxorubicin—bone cancer	0.000608	0.000671	CcSEcCtD
Lamotrigine—Nervous system disorder—Epirubicin—bone cancer	0.000607	0.00067	CcSEcCtD
Lamotrigine—Thrombocytopenia—Epirubicin—bone cancer	0.000606	0.000669	CcSEcCtD
Lamotrigine—Hypertension—Doxorubicin—bone cancer	0.000606	0.000669	CcSEcCtD
Lamotrigine—Tachycardia—Epirubicin—bone cancer	0.000604	0.000667	CcSEcCtD
Lamotrigine—Musculoskeletal discomfort—Methotrexate—bone cancer	0.000603	0.000665	CcSEcCtD
Lamotrigine—Hyperhidrosis—Epirubicin—bone cancer	0.000598	0.000661	CcSEcCtD
Lamotrigine—Insomnia—Methotrexate—bone cancer	0.000598	0.00066	CcSEcCtD
Lamotrigine—Arthralgia—Doxorubicin—bone cancer	0.000598	0.00066	CcSEcCtD
Lamotrigine—Myalgia—Doxorubicin—bone cancer	0.000598	0.00066	CcSEcCtD
Lamotrigine—Chest pain—Doxorubicin—bone cancer	0.000598	0.00066	CcSEcCtD
Lamotrigine—Anxiety—Doxorubicin—bone cancer	0.000595	0.000657	CcSEcCtD
Lamotrigine—ABCB1—Drug Induction of Bile Acid Pathway—CYP3A4—bone cancer	0.000594	0.016	CbGpPWpGaD
Lamotrigine—Paraesthesia—Methotrexate—bone cancer	0.000594	0.000656	CcSEcCtD
Lamotrigine—Discomfort—Doxorubicin—bone cancer	0.00059	0.000652	CcSEcCtD
Lamotrigine—Anorexia—Epirubicin—bone cancer	0.00059	0.000651	CcSEcCtD
Lamotrigine—Dyspnoea—Methotrexate—bone cancer	0.00059	0.000651	CcSEcCtD
Lamotrigine—Somnolence—Methotrexate—bone cancer	0.000588	0.000649	CcSEcCtD
Lamotrigine—Dry mouth—Doxorubicin—bone cancer	0.000584	0.000645	CcSEcCtD
Lamotrigine—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—bone cancer	0.000584	0.0157	CbGpPWpGaD
Lamotrigine—Dyspepsia—Methotrexate—bone cancer	0.000582	0.000643	CcSEcCtD
Lamotrigine—Confusional state—Doxorubicin—bone cancer	0.000578	0.000638	CcSEcCtD
Lamotrigine—Decreased appetite—Methotrexate—bone cancer	0.000575	0.000635	CcSEcCtD
Lamotrigine—Oedema—Doxorubicin—bone cancer	0.000573	0.000632	CcSEcCtD
Lamotrigine—Gastrointestinal disorder—Methotrexate—bone cancer	0.000571	0.00063	CcSEcCtD
Lamotrigine—Fatigue—Methotrexate—bone cancer	0.00057	0.00063	CcSEcCtD
Lamotrigine—Infection—Doxorubicin—bone cancer	0.000569	0.000628	CcSEcCtD
Lamotrigine—Pain—Methotrexate—bone cancer	0.000566	0.000624	CcSEcCtD
Lamotrigine—Musculoskeletal discomfort—Epirubicin—bone cancer	0.000564	0.000623	CcSEcCtD
Lamotrigine—Shock—Doxorubicin—bone cancer	0.000564	0.000622	CcSEcCtD
Lamotrigine—Nervous system disorder—Doxorubicin—bone cancer	0.000562	0.00062	CcSEcCtD
Lamotrigine—Thrombocytopenia—Doxorubicin—bone cancer	0.000561	0.000619	CcSEcCtD
Lamotrigine—Insomnia—Epirubicin—bone cancer	0.00056	0.000618	CcSEcCtD
Lamotrigine—Tachycardia—Doxorubicin—bone cancer	0.000559	0.000617	CcSEcCtD
Lamotrigine—Paraesthesia—Epirubicin—bone cancer	0.000556	0.000614	CcSEcCtD
Lamotrigine—Hyperhidrosis—Doxorubicin—bone cancer	0.000554	0.000611	CcSEcCtD
Lamotrigine—Dyspnoea—Epirubicin—bone cancer	0.000552	0.000609	CcSEcCtD
Lamotrigine—Somnolence—Epirubicin—bone cancer	0.00055	0.000607	CcSEcCtD
Lamotrigine—Anorexia—Doxorubicin—bone cancer	0.000546	0.000603	CcSEcCtD
Lamotrigine—Feeling abnormal—Methotrexate—bone cancer	0.000545	0.000602	CcSEcCtD
Lamotrigine—Dyspepsia—Epirubicin—bone cancer	0.000545	0.000601	CcSEcCtD
Lamotrigine—Gastrointestinal pain—Methotrexate—bone cancer	0.000541	0.000597	CcSEcCtD
Lamotrigine—Decreased appetite—Epirubicin—bone cancer	0.000538	0.000594	CcSEcCtD
Lamotrigine—Gastrointestinal disorder—Epirubicin—bone cancer	0.000534	0.00059	CcSEcCtD
Lamotrigine—Fatigue—Epirubicin—bone cancer	0.000534	0.000589	CcSEcCtD
Lamotrigine—Constipation—Epirubicin—bone cancer	0.000529	0.000584	CcSEcCtD
Lamotrigine—Pain—Epirubicin—bone cancer	0.000529	0.000584	CcSEcCtD
Lamotrigine—Urticaria—Methotrexate—bone cancer	0.000526	0.00058	CcSEcCtD
Lamotrigine—Body temperature increased—Methotrexate—bone cancer	0.000523	0.000577	CcSEcCtD
Lamotrigine—Abdominal pain—Methotrexate—bone cancer	0.000523	0.000577	CcSEcCtD
Lamotrigine—Musculoskeletal discomfort—Doxorubicin—bone cancer	0.000522	0.000576	CcSEcCtD
Lamotrigine—Insomnia—Doxorubicin—bone cancer	0.000518	0.000572	CcSEcCtD
Lamotrigine—UGT1A4—Phase II conjugation—GSTP1—bone cancer	0.000518	0.0139	CbGpPWpGaD
Lamotrigine—Paraesthesia—Doxorubicin—bone cancer	0.000514	0.000568	CcSEcCtD
Lamotrigine—Dyspnoea—Doxorubicin—bone cancer	0.000511	0.000564	CcSEcCtD
Lamotrigine—Feeling abnormal—Epirubicin—bone cancer	0.00051	0.000563	CcSEcCtD
Lamotrigine—Somnolence—Doxorubicin—bone cancer	0.000509	0.000562	CcSEcCtD
Lamotrigine—Gastrointestinal pain—Epirubicin—bone cancer	0.000506	0.000559	CcSEcCtD
Lamotrigine—Dyspepsia—Doxorubicin—bone cancer	0.000504	0.000557	CcSEcCtD
Lamotrigine—Decreased appetite—Doxorubicin—bone cancer	0.000498	0.00055	CcSEcCtD
Lamotrigine—Gastrointestinal disorder—Doxorubicin—bone cancer	0.000495	0.000546	CcSEcCtD
Lamotrigine—Fatigue—Doxorubicin—bone cancer	0.000494	0.000545	CcSEcCtD
Lamotrigine—Urticaria—Epirubicin—bone cancer	0.000492	0.000543	CcSEcCtD
Lamotrigine—Pain—Doxorubicin—bone cancer	0.00049	0.000541	CcSEcCtD
Lamotrigine—Constipation—Doxorubicin—bone cancer	0.00049	0.000541	CcSEcCtD
Lamotrigine—Abdominal pain—Epirubicin—bone cancer	0.000489	0.00054	CcSEcCtD
Lamotrigine—Body temperature increased—Epirubicin—bone cancer	0.000489	0.00054	CcSEcCtD
Lamotrigine—Hypersensitivity—Methotrexate—bone cancer	0.000487	0.000538	CcSEcCtD
Lamotrigine—Asthenia—Methotrexate—bone cancer	0.000475	0.000524	CcSEcCtD
Lamotrigine—Feeling abnormal—Doxorubicin—bone cancer	0.000472	0.000521	CcSEcCtD
Lamotrigine—Gastrointestinal pain—Doxorubicin—bone cancer	0.000468	0.000517	CcSEcCtD
Lamotrigine—Pruritus—Methotrexate—bone cancer	0.000468	0.000517	CcSEcCtD
Lamotrigine—Hypersensitivity—Epirubicin—bone cancer	0.000456	0.000503	CcSEcCtD
Lamotrigine—Urticaria—Doxorubicin—bone cancer	0.000455	0.000502	CcSEcCtD
Lamotrigine—Abdominal pain—Doxorubicin—bone cancer	0.000453	0.0005	CcSEcCtD
Lamotrigine—Body temperature increased—Doxorubicin—bone cancer	0.000453	0.0005	CcSEcCtD
Lamotrigine—Diarrhoea—Methotrexate—bone cancer	0.000453	0.0005	CcSEcCtD
Lamotrigine—Asthenia—Epirubicin—bone cancer	0.000444	0.00049	CcSEcCtD
Lamotrigine—Pruritus—Epirubicin—bone cancer	0.000438	0.000483	CcSEcCtD
Lamotrigine—Dizziness—Methotrexate—bone cancer	0.000437	0.000483	CcSEcCtD
Lamotrigine—UGT1A3—Phase II conjugation—GSTP1—bone cancer	0.00043	0.0116	CbGpPWpGaD
Lamotrigine—Diarrhoea—Epirubicin—bone cancer	0.000424	0.000468	CcSEcCtD
Lamotrigine—SCN5A—Cardiac Progenitor Differentiation—KIT—bone cancer	0.000422	0.0114	CbGpPWpGaD
Lamotrigine—Hypersensitivity—Doxorubicin—bone cancer	0.000422	0.000466	CcSEcCtD
Lamotrigine—Vomiting—Methotrexate—bone cancer	0.000421	0.000464	CcSEcCtD
Lamotrigine—Rash—Methotrexate—bone cancer	0.000417	0.00046	CcSEcCtD
Lamotrigine—Dermatitis—Methotrexate—bone cancer	0.000417	0.00046	CcSEcCtD
Lamotrigine—Headache—Methotrexate—bone cancer	0.000414	0.000457	CcSEcCtD
Lamotrigine—Asthenia—Doxorubicin—bone cancer	0.000411	0.000454	CcSEcCtD
Lamotrigine—Dizziness—Epirubicin—bone cancer	0.000409	0.000452	CcSEcCtD
Lamotrigine—UGT1A4—Aryl Hydrocarbon Receptor Pathway—JUN—bone cancer	0.000406	0.0109	CbGpPWpGaD
Lamotrigine—Pruritus—Doxorubicin—bone cancer	0.000405	0.000447	CcSEcCtD
Lamotrigine—Vomiting—Epirubicin—bone cancer	0.000394	0.000434	CcSEcCtD
Lamotrigine—Nausea—Methotrexate—bone cancer	0.000393	0.000434	CcSEcCtD
Lamotrigine—Diarrhoea—Doxorubicin—bone cancer	0.000392	0.000433	CcSEcCtD
Lamotrigine—Rash—Epirubicin—bone cancer	0.00039	0.000431	CcSEcCtD
Lamotrigine—Dermatitis—Epirubicin—bone cancer	0.00039	0.00043	CcSEcCtD
Lamotrigine—Headache—Epirubicin—bone cancer	0.000388	0.000428	CcSEcCtD
Lamotrigine—Dizziness—Doxorubicin—bone cancer	0.000379	0.000418	CcSEcCtD
Lamotrigine—Nausea—Epirubicin—bone cancer	0.000368	0.000406	CcSEcCtD
Lamotrigine—Vomiting—Doxorubicin—bone cancer	0.000364	0.000402	CcSEcCtD
Lamotrigine—Rash—Doxorubicin—bone cancer	0.000361	0.000399	CcSEcCtD
Lamotrigine—Dermatitis—Doxorubicin—bone cancer	0.000361	0.000398	CcSEcCtD
Lamotrigine—Headache—Doxorubicin—bone cancer	0.000359	0.000396	CcSEcCtD
Lamotrigine—ABCB1—Constitutive Androstane Receptor Pathway—CYP3A4—bone cancer	0.000358	0.00963	CbGpPWpGaD
Lamotrigine—UGT1A4—Biological oxidations—CYP3A4—bone cancer	0.000354	0.00951	CbGpPWpGaD
Lamotrigine—UGT1A4—Metapathway biotransformation—CYP3A4—bone cancer	0.000349	0.00938	CbGpPWpGaD
Lamotrigine—UGT1A4—NRF2 pathway—GSTP1—bone cancer	0.000345	0.00928	CbGpPWpGaD
Lamotrigine—UGT1A4—NRF2 pathway—TGFBR2—bone cancer	0.000345	0.00928	CbGpPWpGaD
Lamotrigine—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP3A4—bone cancer	0.000341	0.00917	CbGpPWpGaD
Lamotrigine—Nausea—Doxorubicin—bone cancer	0.00034	0.000376	CcSEcCtD
Lamotrigine—UGT1A3—Aryl Hydrocarbon Receptor Pathway—JUN—bone cancer	0.000338	0.00908	CbGpPWpGaD
Lamotrigine—UGT1A4—Aryl Hydrocarbon Receptor Pathway—EGFR—bone cancer	0.000319	0.00858	CbGpPWpGaD
Lamotrigine—UGT1A4—Biological oxidations—GSTP1—bone cancer	0.000303	0.00814	CbGpPWpGaD
Lamotrigine—UGT1A4—Metapathway biotransformation—GSTP1—bone cancer	0.000299	0.00803	CbGpPWpGaD
Lamotrigine—UGT1A3—Biological oxidations—CYP3A4—bone cancer	0.000294	0.00791	CbGpPWpGaD
Lamotrigine—UGT1A3—Metapathway biotransformation—CYP3A4—bone cancer	0.00029	0.0078	CbGpPWpGaD
Lamotrigine—UGT1A3—NRF2 pathway—TGFBR2—bone cancer	0.000287	0.00771	CbGpPWpGaD
Lamotrigine—UGT1A3—NRF2 pathway—GSTP1—bone cancer	0.000287	0.00771	CbGpPWpGaD
Lamotrigine—SCN8A—L1CAM interactions—EGFR—bone cancer	0.000281	0.00754	CbGpPWpGaD
Lamotrigine—UGT1A3—Aryl Hydrocarbon Receptor Pathway—EGFR—bone cancer	0.000266	0.00714	CbGpPWpGaD
Lamotrigine—UGT1A3—Biological oxidations—GSTP1—bone cancer	0.000252	0.00676	CbGpPWpGaD
Lamotrigine—UGT1A3—Metapathway biotransformation—GSTP1—bone cancer	0.000248	0.00667	CbGpPWpGaD
Lamotrigine—SCN9A—L1CAM interactions—EGFR—bone cancer	0.000227	0.0061	CbGpPWpGaD
Lamotrigine—SCN3A—L1CAM interactions—EGFR—bone cancer	0.000217	0.00583	CbGpPWpGaD
Lamotrigine—UGT1A4—Metabolism—NDUFA12—bone cancer	0.000212	0.0057	CbGpPWpGaD
Lamotrigine—SCN8A—Axon guidance—MET—bone cancer	0.000209	0.00562	CbGpPWpGaD
Lamotrigine—SCN2A—L1CAM interactions—EGFR—bone cancer	0.000209	0.0056	CbGpPWpGaD
Lamotrigine—SCN4A—L1CAM interactions—EGFR—bone cancer	0.000209	0.0056	CbGpPWpGaD
Lamotrigine—SCN1A—L1CAM interactions—EGFR—bone cancer	0.000201	0.0054	CbGpPWpGaD
Lamotrigine—SCN10A—L1CAM interactions—EGFR—bone cancer	0.000201	0.0054	CbGpPWpGaD
Lamotrigine—UGT1A3—Metabolism—NDUFA12—bone cancer	0.000176	0.00474	CbGpPWpGaD
Lamotrigine—UGT1A4—Metabolism—NT5C3A—bone cancer	0.000176	0.00473	CbGpPWpGaD
Lamotrigine—SCN8A—Axon guidance—MMP2—bone cancer	0.000175	0.00469	CbGpPWpGaD
Lamotrigine—SCN9A—Axon guidance—MET—bone cancer	0.000169	0.00455	CbGpPWpGaD
Lamotrigine—SCN3A—Axon guidance—MET—bone cancer	0.000162	0.00435	CbGpPWpGaD
Lamotrigine—SCN4A—Axon guidance—MET—bone cancer	0.000156	0.00418	CbGpPWpGaD
Lamotrigine—SCN2A—Axon guidance—MET—bone cancer	0.000156	0.00418	CbGpPWpGaD
Lamotrigine—SCN10A—Axon guidance—MET—bone cancer	0.00015	0.00403	CbGpPWpGaD
Lamotrigine—SCN1A—Axon guidance—MET—bone cancer	0.00015	0.00403	CbGpPWpGaD
Lamotrigine—SCN8A—Developmental Biology—CDK4—bone cancer	0.000149	0.00401	CbGpPWpGaD
Lamotrigine—SCN8A—Developmental Biology—MET—bone cancer	0.000149	0.00401	CbGpPWpGaD
Lamotrigine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—bone cancer	0.000149	0.004	CbGpPWpGaD
Lamotrigine—UGT1A3—Metabolism—NT5C3A—bone cancer	0.000146	0.00393	CbGpPWpGaD
Lamotrigine—SCN5A—L1CAM interactions—EGFR—bone cancer	0.000141	0.0038	CbGpPWpGaD
Lamotrigine—SCN9A—Axon guidance—MMP2—bone cancer	0.000141	0.00379	CbGpPWpGaD
Lamotrigine—SCN3A—Axon guidance—MMP2—bone cancer	0.000135	0.00363	CbGpPWpGaD
Lamotrigine—SCN8A—Axon guidance—MMP9—bone cancer	0.000131	0.00353	CbGpPWpGaD
Lamotrigine—SCN2A—Axon guidance—MMP2—bone cancer	0.00013	0.00349	CbGpPWpGaD
Lamotrigine—SCN4A—Axon guidance—MMP2—bone cancer	0.00013	0.00349	CbGpPWpGaD
Lamotrigine—SCN1A—Axon guidance—MMP2—bone cancer	0.000125	0.00336	CbGpPWpGaD
Lamotrigine—SCN10A—Axon guidance—MMP2—bone cancer	0.000125	0.00336	CbGpPWpGaD
Lamotrigine—SCN8A—Developmental Biology—MMP2—bone cancer	0.000125	0.00335	CbGpPWpGaD
Lamotrigine—SCN5A—SIDS Susceptibility Pathways—JUN—bone cancer	0.000122	0.00328	CbGpPWpGaD
Lamotrigine—ABCB1—Integrated Pancreatic Cancer Pathway—WT1—bone cancer	0.000122	0.00327	CbGpPWpGaD
Lamotrigine—SCN9A—Developmental Biology—MET—bone cancer	0.000121	0.00325	CbGpPWpGaD
Lamotrigine—SCN9A—Developmental Biology—CDK4—bone cancer	0.000121	0.00325	CbGpPWpGaD
Lamotrigine—SCN3A—Developmental Biology—CDK4—bone cancer	0.000116	0.0031	CbGpPWpGaD
Lamotrigine—SCN3A—Developmental Biology—MET—bone cancer	0.000116	0.0031	CbGpPWpGaD
Lamotrigine—SCN2A—Developmental Biology—CDK4—bone cancer	0.000111	0.00298	CbGpPWpGaD
Lamotrigine—SCN4A—Developmental Biology—CDK4—bone cancer	0.000111	0.00298	CbGpPWpGaD
Lamotrigine—SCN2A—Developmental Biology—MET—bone cancer	0.000111	0.00298	CbGpPWpGaD
Lamotrigine—SCN4A—Developmental Biology—MET—bone cancer	0.000111	0.00298	CbGpPWpGaD
Lamotrigine—SCN1A—Developmental Biology—CDK4—bone cancer	0.000107	0.00288	CbGpPWpGaD
Lamotrigine—SCN10A—Developmental Biology—MET—bone cancer	0.000107	0.00288	CbGpPWpGaD
Lamotrigine—SCN1A—Developmental Biology—MET—bone cancer	0.000107	0.00288	CbGpPWpGaD
Lamotrigine—SCN10A—Developmental Biology—CDK4—bone cancer	0.000107	0.00288	CbGpPWpGaD
Lamotrigine—SCN9A—Axon guidance—MMP9—bone cancer	0.000106	0.00285	CbGpPWpGaD
Lamotrigine—SCN8A—Axon guidance—EGFR—bone cancer	0.000106	0.00285	CbGpPWpGaD
Lamotrigine—SCN5A—Axon guidance—MET—bone cancer	0.000105	0.00283	CbGpPWpGaD
Lamotrigine—ABCB1—Integrated Pancreatic Cancer Pathway—SMO—bone cancer	0.000103	0.00278	CbGpPWpGaD
Lamotrigine—SCN3A—Axon guidance—MMP9—bone cancer	0.000102	0.00273	CbGpPWpGaD
Lamotrigine—SCN9A—Developmental Biology—MMP2—bone cancer	0.000101	0.00271	CbGpPWpGaD
Lamotrigine—SCN2A—Axon guidance—MMP9—bone cancer	9.75e-05	0.00262	CbGpPWpGaD
Lamotrigine—SCN4A—Axon guidance—MMP9—bone cancer	9.75e-05	0.00262	CbGpPWpGaD
Lamotrigine—SCN3A—Developmental Biology—MMP2—bone cancer	9.64e-05	0.00259	CbGpPWpGaD
Lamotrigine—ABCB1—Integrated Pancreatic Cancer Pathway—EZH2—bone cancer	9.42e-05	0.00253	CbGpPWpGaD
Lamotrigine—SCN1A—Axon guidance—MMP9—bone cancer	9.4e-05	0.00253	CbGpPWpGaD
Lamotrigine—SCN10A—Axon guidance—MMP9—bone cancer	9.4e-05	0.00253	CbGpPWpGaD
Lamotrigine—SCN8A—Developmental Biology—MMP9—bone cancer	9.36e-05	0.00252	CbGpPWpGaD
Lamotrigine—SCN2A—Developmental Biology—MMP2—bone cancer	9.26e-05	0.00249	CbGpPWpGaD
Lamotrigine—SCN4A—Developmental Biology—MMP2—bone cancer	9.26e-05	0.00249	CbGpPWpGaD
Lamotrigine—SCN1A—Developmental Biology—MMP2—bone cancer	8.93e-05	0.0024	CbGpPWpGaD
Lamotrigine—SCN10A—Developmental Biology—MMP2—bone cancer	8.93e-05	0.0024	CbGpPWpGaD
Lamotrigine—SCN5A—Axon guidance—MMP2—bone cancer	8.8e-05	0.00236	CbGpPWpGaD
Lamotrigine—ABCB1—Integrated Pancreatic Cancer Pathway—IL3—bone cancer	8.58e-05	0.00231	CbGpPWpGaD
Lamotrigine—SCN9A—Axon guidance—EGFR—bone cancer	8.58e-05	0.0023	CbGpPWpGaD
Lamotrigine—ABCB1—Integrated Pancreatic Cancer Pathway—CHEK2—bone cancer	8.46e-05	0.00227	CbGpPWpGaD
Lamotrigine—SCN3A—Axon guidance—EGFR—bone cancer	8.2e-05	0.0022	CbGpPWpGaD
Lamotrigine—ABCB1—HIF-1-alpha transcription factor network—JUN—bone cancer	8.02e-05	0.00216	CbGpPWpGaD
Lamotrigine—SCN2A—Axon guidance—EGFR—bone cancer	7.88e-05	0.00212	CbGpPWpGaD
Lamotrigine—SCN4A—Axon guidance—EGFR—bone cancer	7.88e-05	0.00212	CbGpPWpGaD
Lamotrigine—UGT1A4—Metabolism—ENO2—bone cancer	7.7e-05	0.00207	CbGpPWpGaD
Lamotrigine—SCN1A—Axon guidance—EGFR—bone cancer	7.6e-05	0.00204	CbGpPWpGaD
Lamotrigine—SCN10A—Axon guidance—EGFR—bone cancer	7.6e-05	0.00204	CbGpPWpGaD
Lamotrigine—SCN9A—Developmental Biology—MMP9—bone cancer	7.57e-05	0.00204	CbGpPWpGaD
Lamotrigine—SCN8A—Developmental Biology—EGFR—bone cancer	7.57e-05	0.00203	CbGpPWpGaD
Lamotrigine—SCN5A—Developmental Biology—CDK4—bone cancer	7.52e-05	0.00202	CbGpPWpGaD
Lamotrigine—SCN5A—Developmental Biology—MET—bone cancer	7.52e-05	0.00202	CbGpPWpGaD
Lamotrigine—SCN3A—Developmental Biology—MMP9—bone cancer	7.24e-05	0.00195	CbGpPWpGaD
Lamotrigine—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—bone cancer	7.17e-05	0.00193	CbGpPWpGaD
Lamotrigine—ABCB1—Transmembrane transport of small molecules—TUBB4B—bone cancer	7.15e-05	0.00192	CbGpPWpGaD
Lamotrigine—UGT1A4—Metabolism—DHFR—bone cancer	7.15e-05	0.00192	CbGpPWpGaD
Lamotrigine—SCN2A—Developmental Biology—MMP9—bone cancer	6.96e-05	0.00187	CbGpPWpGaD
Lamotrigine—SCN4A—Developmental Biology—MMP9—bone cancer	6.96e-05	0.00187	CbGpPWpGaD
Lamotrigine—SCN10A—Developmental Biology—MMP9—bone cancer	6.71e-05	0.0018	CbGpPWpGaD
Lamotrigine—SCN1A—Developmental Biology—MMP9—bone cancer	6.71e-05	0.0018	CbGpPWpGaD
Lamotrigine—UGT1A4—Metabolism—GNA11—bone cancer	6.68e-05	0.00179	CbGpPWpGaD
Lamotrigine—SCN5A—Axon guidance—MMP9—bone cancer	6.61e-05	0.00178	CbGpPWpGaD
Lamotrigine—UGT1A3—Metabolism—ENO2—bone cancer	6.4e-05	0.00172	CbGpPWpGaD
Lamotrigine—SCN5A—Developmental Biology—MMP2—bone cancer	6.28e-05	0.00169	CbGpPWpGaD
Lamotrigine—ABCB1—Transmembrane transport of small molecules—TUBB2A—bone cancer	6.17e-05	0.00166	CbGpPWpGaD
Lamotrigine—SCN9A—Developmental Biology—EGFR—bone cancer	6.12e-05	0.00164	CbGpPWpGaD
Lamotrigine—UGT1A4—Metabolism—CYP3A4—bone cancer	6.06e-05	0.00163	CbGpPWpGaD
Lamotrigine—UGT1A3—Metabolism—DHFR—bone cancer	5.94e-05	0.0016	CbGpPWpGaD
Lamotrigine—SCN3A—Developmental Biology—EGFR—bone cancer	5.85e-05	0.00157	CbGpPWpGaD
Lamotrigine—SCN4A—Developmental Biology—EGFR—bone cancer	5.62e-05	0.00151	CbGpPWpGaD
Lamotrigine—SCN2A—Developmental Biology—EGFR—bone cancer	5.62e-05	0.00151	CbGpPWpGaD
Lamotrigine—ABCB1—Metabolism—NDUFA12—bone cancer	5.59e-05	0.0015	CbGpPWpGaD
Lamotrigine—UGT1A3—Metabolism—GNA11—bone cancer	5.55e-05	0.00149	CbGpPWpGaD
Lamotrigine—SCN1A—Developmental Biology—EGFR—bone cancer	5.42e-05	0.00146	CbGpPWpGaD
Lamotrigine—SCN10A—Developmental Biology—EGFR—bone cancer	5.42e-05	0.00146	CbGpPWpGaD
Lamotrigine—SCN5A—Axon guidance—EGFR—bone cancer	5.34e-05	0.00144	CbGpPWpGaD
Lamotrigine—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—bone cancer	5.32e-05	0.00143	CbGpPWpGaD
Lamotrigine—UGT1A4—Metabolism—GSTP1—bone cancer	5.18e-05	0.00139	CbGpPWpGaD
Lamotrigine—UGT1A3—Metabolism—CYP3A4—bone cancer	5.03e-05	0.00135	CbGpPWpGaD
Lamotrigine—SCN5A—Developmental Biology—MMP9—bone cancer	4.72e-05	0.00127	CbGpPWpGaD
Lamotrigine—ABCB1—Metabolism—NT5C3A—bone cancer	4.63e-05	0.00125	CbGpPWpGaD
Lamotrigine—UGT1A3—Metabolism—GSTP1—bone cancer	4.3e-05	0.00116	CbGpPWpGaD
Lamotrigine—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—bone cancer	3.94e-05	0.00106	CbGpPWpGaD
Lamotrigine—SCN5A—Developmental Biology—EGFR—bone cancer	3.81e-05	0.00102	CbGpPWpGaD
Lamotrigine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—bone cancer	3.8e-05	0.00102	CbGpPWpGaD
Lamotrigine—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—bone cancer	3.43e-05	0.000921	CbGpPWpGaD
Lamotrigine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—bone cancer	2.69e-05	0.000724	CbGpPWpGaD
Lamotrigine—UGT1A4—Metabolism—PTGS2—bone cancer	2.68e-05	0.000721	CbGpPWpGaD
Lamotrigine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—bone cancer	2.26e-05	0.000608	CbGpPWpGaD
Lamotrigine—UGT1A3—Metabolism—PTGS2—bone cancer	2.23e-05	0.000599	CbGpPWpGaD
Lamotrigine—ABCB1—Metabolism—ENO2—bone cancer	2.03e-05	0.000545	CbGpPWpGaD
Lamotrigine—ABCB1—Metabolism—DHFR—bone cancer	1.88e-05	0.000506	CbGpPWpGaD
Lamotrigine—ABCB1—Metabolism—GNA11—bone cancer	1.76e-05	0.000473	CbGpPWpGaD
Lamotrigine—ABCB1—Metabolism—CYP3A4—bone cancer	1.6e-05	0.000429	CbGpPWpGaD
Lamotrigine—ABCB1—Metabolism—GSTP1—bone cancer	1.36e-05	0.000367	CbGpPWpGaD
Lamotrigine—ABCB1—Metabolism—PTGS2—bone cancer	7.07e-06	0.00019	CbGpPWpGaD
